Clinical trial

Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma

NCT02901236

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2016-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

Standard Guarded TrabeculectomyPROCEDURE

Mitomycin CDRUG

BevacizumabDRUG · verified · RxNorm: bevacizumab

Sponsors & collaborators

Athens Vision Eye Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02901236 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.